|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by (used in) operating activities: | |||||
| Provision for (reversal of) credit losses | |||||
| Depreciation, amortization, and accretion, net | |||||
| Deferred income tax expense (benefit) | |||||
| Originations of loans held for sale | |||||
| Proceeds from sales of loans held for sale | |||||
| Gain on sales of loans held for sale, net | |||||
| (Increase) decrease in other assets | |||||
| Increase (decrease) in other liabilities | |||||
| Investment securities (gains) losses, net | |||||
| Share-based compensation expense | |||||
| Loss on sales of loans | |||||
| Net gain on sales of other real estate and other assets held for sale | |||||
| Other | |||||
| Net cash provided by (used in) operating activities | |||||
| Investing Activities | |||||
| Net cash received (paid) for business combination and divestiture | |||||
| Proceeds from maturities and principal collections of investment securities held to maturity | |||||
| Proceeds from maturities and principal collections of investment securities available for sale | |||||
| Proceeds from sales of investment securities available for sale | |||||
| Purchases of investment securities available for sale | |||||
| Net proceeds from sales of loans | |||||
| Purchases of loans | |||||
| Net (increase) decrease in loans | |||||
| Net (purchases) redemptions of Federal Reserve Bank stock | |||||
| Net (purchases) redemptions of Federal Home Loan Bank stock | |||||
| Net (purchases) proceeds from settlement of bank-owned life insurance policies | |||||
| Net increase in premises, equipment and software | |||||
| Proceeds from sales of other real estate and other assets held for sale | |||||
| Net cash provided by (used in) investing activities | |||||
| Financing Activities | |||||
| Net increase (decrease) in deposits | |||||
| Net increase (decrease) in federal funds purchased and securities sold under repurchase agreements | |||||
| Net increase (decrease) in other short-term borrowings | |||||
| Repayments and redemption of long-term debt | |||||
| Proceeds from long-term debt, net | |||||
| Dividends paid to common shareholders | |||||
| Dividends paid to preferred shareholders | |||||
| Issuances, net of taxes paid, under equity compensation plans | |||||
| Repurchase of common stock | |||||
| Other | |||||
| Net cash provided by (used in) financing activities | |||||
| Increase (decrease) in cash and cash equivalents including restricted cash | |||||
| Cash, cash equivalents, and restricted cash at beginning of year | |||||
| Cash, cash equivalents, and restricted cash at end of year | |||||
| Supplemental Disclosures: | |||||
| Income taxes paid | |||||
| Interest paid | |||||
| Non-cash Activities: | |||||
| Loans transferred to (from) loans held for sale at fair value | |||||
| Premises and equipment transferred to other assets held for sale | |||||
| Loans foreclosed and transferred to other real estate | |||||
| Investment securities transferred from available for sale to held to maturity | |||||
| Settlement of acquired debt | |||||
Loading...